Tag: PR

OptraSCAN Digital Pathology Launches On-Demand Image Analysis Suite at USCAP 2017

| March 6, 2017 | 0 Comments

Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN, Inc. today announced the launch of its next generation, On-Demand suite of image analysis software for digital pathology, which includes OptraASSAYSTM, CARDSTM and OptraPROCESSTM. The image analysis suite supports both individual, […]

Continue Reading

OptraSCAN Announces the Availability of a Breast Cancer-Focused Panel of Algorithmic Biomarkers as Part of its On-Demand Model

| July 14, 2016 | 0 Comments

OptraSCANTM On-Demand Digital Pathology announced today the availability of a Breast Cancer Focused Panel of Algorithmic Biomarkers (ER/PR, HER-2/neu, Ki67, P53, EGFR, AE1/AE3) through its OptraASSAYSTM and OptraCARDSTM Solutions, as part of its subscription-based model (starting at $1,950 per month for a six-month commitment, which includes: the OptraSCAN Scanner, Data Storage, TELEPath Telepathology and Service). […]

Continue Reading

Philips Teams Up With Visiopharm to Boost Breast Cancer Diagnosis Objectivity Through Computational Pathology

| June 22, 2016 | 0 Comments

More news from Philips this week – announcing a licensing agreement with Visiopharm to combine Visiopharm’s breast cancer panel with Philips’ Intellisite digital pathology solution. From a scientific standpoint, as the references mentioned point out, image analysis is critical to appropriate patient care, increasing consistency and reproducibility, if not accuracy, with increased efficiencies for pathologists […]

Continue Reading

Use of Aperio Image Analysis in Peer Reviewed Breast Cancer Research

| April 14, 2016 | 0 Comments

Leica Biosystems was kind enough to share with me a recent white paper on “Use of Aperio Image Analysis in Peer Reviewed Breast Cancer Research” This is a lengthy review of 30 articles published in peer-reviewed scientific journals, which use Aperio Image Analysis for research into aspects of breast cancer, including disease development, prognostic markers, and clinical […]

Continue Reading

Join Omnyx for a Webinar!

| April 10, 2016 | 0 Comments

Quantification Algorithms: Value and Progress in Standardization of IHC Breast Tissue Data April 13th, 2016 12:00 PM EST Michael Grunkin, Ph.D. Chief Executive Officer Visiopharm In collaboration with Visiopharm®, Dynamyx™ software provides pathologists sophisticated tools that incorporate precision, quantification and confidence in decision-making for breast panel analysis (HER2, ER, PR, Ki67). These algorithms give pathologists […]

Continue Reading

Applied Spectral Imaging received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

| April 16, 2015 | 0 Comments

Carlsbad, CA. – April 16, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image capture and analysis platform. The South Korean market is a key market for ASI’s computer-aided imaging solutions for pathology, which […]

Continue Reading

Three Events – One Product Family! Join ASI in March!

| March 17, 2015 | 0 Comments

Three Events – One Product Family! Join Applied Spectral Imaging at the following events in March to learn about ASI’s GenASIs Platform. Accurate. Standardized. Immediate USCAP 2015 – United States & Canadian Academy of Pathology Annual Meeting March 23-25 | Hynes Convention Center, Boston, MA, USA | Booth # 519 ACMG 2015 – Annual Clinical […]

Continue Reading

Herlev University Hospital Selects ONCOtopix Dx for Routine Cancer Diagnostics

| March 9, 2015 | 0 Comments

After thorough testing, and internal clinical validation, Herlev University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization (ISH). “Herlev University Hospital was the first diagnostic pathology lab in Denmark to adopt digital pathology and image analysis in routine clinical work. It has been important for […]

Continue Reading

Applied Spectral Imaging receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

| January 22, 2015 | 0 Comments

Carlsbad, CA. – January 21, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis platform. ASI’s GenASIs HiPath IHC Family is an advanced image analysis platform for IHC and CISH samples that integrates with existing lab […]

Continue Reading

Automation and Increased Accuracy for Hormone Receptors in Breast Cancer

| September 12, 2014 | 0 Comments

Join Visiopharm next week for a webinar titled, “Hormone Receptors in Breast Cancer: Automation and Increased Accuracy” on September 16, 2014 at 4 PM CET / 10 AM EST / 7 AM PST. Estrogen (ER) and progesterone (PR; PgR) evaluation is routinely used for clinical breast cancer assessment. While ER is known to have a […]

Continue Reading

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope

| July 25, 2014 | 0 Comments

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope A complete solution for FISH, CISH and IHC Applied Spectral Imaging Inc. develops computer aided image analysis & diagnostic tools for clinical and research applications. The GenASIs platform integrates within the existing workflow of the microscope, pathologist and LIS framework, […]

Continue Reading